Anales RANF

Dolores Prieto Ocejo @Real Academia Nacional de Farmacia. Spain 299 Endothelium-derived hyperpolarizing factor synthase (Cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries. Circ Res 2001; 88: 44-51 16. Brandes RP, Weissmann N, Schröder K. Nox family NADPH oxidases: Molecular mechanisms of activation. Free Radic Biol Med 2014; 76: 208-26. 17. Schröder K, Weissmann N, Brandes RP. Organizers and activators: Cytosolic Nox proteins impacting on vascular function. Free Radic Biol Med 2017; 109: 22-32. 18. Drummond GR, Sobey CG. Endothelial NADPH oxidases: which NOX to target in vascular disease?Trends Endocrinol Metab 2014; 25: 452-63. 19. Schröder K, Zhang M, Benkhoff S, Mieth A, Pliquett R, Kosowski J, Kruse C, Luedike P, Michaelis UR, Weissmann N, Dimmeler S, Shah AM, Brandes RP. Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase. Circ Res 2012; 110: 1217-25. 20. Sedeek M, Nasrallah R, Touyz RM, Hébert RL. NADPH oxidases, reactive oxygen species, and the kidney: friend and foe. J Am Soc Nephrol 2013; 240): 1512-8. 21. Gorin Y, Block K. Nox4 and diabetic nephropathy: with a friend like this, who needs enemies? Free Radic Biol Med 2013; 61: 130-4. 22. Muñoz M, Martínez MP, López-Oliva ME, Rodríguez C, Corbacho C, Carballido J, García-Sacristán A, Hernández M, Rivera L, Sáenz-Medina J, Prieto D. Hydrogen peroxide derived from NADPH oxidase 4- and 2 contributes to the endothelium-dependent vasodilatation of intrarenal arteries. Redox Biol. 2018; 19: 92-104. 23. Wisse BE, Kim F, Schwartz MW. An integrative view of obesity. Science 2007; 318: 928-9. 24. Bays HE, Toth PP, Kris-Etherton PM, Abate N, Aronne LJ, Brown WV, Gonzalez-Campoy JM, Jones SR, Kumar R, La Forge R, Samuel VT. Obesity, adiposity, and dyslipidemia: A consensus statement from the National Lipid Association. Journal of Clinical Lipidology 2013; 7: 304-383 25. Bakker W, Eringa EC, Sipkema P, van Hinsbergh VW. Endothelial dysfunction and diabetes: roles of hyperglycemia, impaired insulin signaling and obesity. Cell Tissue Res 2009; 335: 165-89. 26. Keaney JF Jr, Larson MG, Vasan RS, Wilson PW, Lipinska I, Corey D, Massaro JM, Sutherland P, Vita JA, Benjamin EJ. Framingham Study. Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol 2003; 23: 434-9. 27. Galili O, Versari D, Sattler KJ, Olson ML, Mannheim D, McConnell JP, Chade AR, Lerman LO, Lerman A. Early experimental obesity is associated with coronary endothelial dysfunction and oxidative stress. Am J Physiol Heart Circ Physiol 2007; 292: H904-1. 28. Alexander CM, Landsman PB, Teutsch TM, Haffner SM. NCEP-defined metabolic syndrome, diabetes, and prevalence of coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-14. 29. Villalba N, Martínez P, Bríones AM, Sánchez A, Salaices M, García-Sacristán A, Hernández M, Benedito S, Prieto D. Differential structural and functional changes in penile and coronary arteries from obese Zucker rats. Am J Physiol Heart Circ Physiol 2009; 297: H696-707. 30. Contreras C, Sánchez A, García-Sacristán A, Martínez MC, Andriantsitohaina R, Prieto D. Preserved insulin vasorelaxation and up-regulation of the Akt/eNOS pathway in coronary arteries from insulin resistant obese Zucker rats. Atherosclerosis 2011; 217: 331-9. 31. Shi Y, Vanhoutte PM. Oxidative stress and COX cause hyper-responsiveness in vascular smooth muscle of the femoral artery from diabetic rats. Br J Pharmacol 2008; 154: 639-51. 32. Tian XY, Wong WT, Leung FP, Zhang Y, Wang YX, Lee HK, Ng CF, Chen ZY, Yao X, Au CL, Lau CW, Vanhoutte PM, Cooke JP, Huang Y. Oxidative stress- dependent cyclooxygenase-2-derived prostaglandin f(2 α ) impairs endothelial function in renovascular hypertensive rats. Antioxid Redox Signal 2012; 16: 363-73. 33. Martínez-Revelles S, Avendaño MS, García- Redondo AB, Alvarez Y, Aguado A, Pérez-Girón JV, García-Redondo L, Esteban V, Redondo JM, Alonso MJ, Briones AM, Salaices M. Reciprocal relationship between reactive oxygen species and cyclooxygenase-2 and vascular dysfunction in hypertension. Antioxid Redox Signal 2013; 18: 1851-65. 34. Sánchez A, Contreras C, Martínez P, Villalba N, Benedito S, García-Sacristán A, Salaices M, Hernández M, Prieto D. Enhanced cyclooxygenase 2-mediated vasorelaxation in coronary arteries from insulin-resistant obese Zucker rats. Atherosclerosis 2010; 213: 392-9. 35. Santiago E, Martínez MP, Climent B, Muñoz M, Briones AM, Salaices M, García-Sacristán A, Rivera L, Prieto D. Augmented oxidative stress and preserved vasoconstriction induced by hydrogen peroxide in coronary arteries in obesity: role of COX-2. Br J Pharmacol 2016; 173: 3176-95. 36. Szerafin T, Erdei N, Fülöp T, Pasztor ET, Edes I, Koller A, Bagi Z. Increased cyclooxygenase-2 expression and prostaglandin-mediated dilation in coronary arterioles of patients with diabetes mellitus. Circ Res 2006; 99: e12- 7 37. Tang SY, Monslow J, Todd L, Lawson J, Puré E, Fitz Gerald GA. Cyclooxygenase-2 in endothelial and vascular smooth muscle cells restrains atherogenesis in hyperlipidemic mice. Circulation 2014; 129: 1761-1769. 38. Yasui M, Tamura Y, Minami M, Higuchi S, Fujikawa R, Ikedo T et al. (2015). The Prostaglandin E 2 receptor EP 4 regulates obesity related inflammation and insulin sensitivity. PLoS One 10: e0136304. 39. Bhala N, Emberson J, Merhi A, Abramson S, Arber